Paper Details
- Home
- Paper Details
Incidence of adverse events requiring intervention after initiation of oral beta-blocker in pediatric cardiac intensive care patients.
Author: BrittJolie, BronickiRonald A, ChecchiaPaul A, MoffettBrady S
Original Abstract of the Article :
Only limited clinical data are available to establish the risk factors for adverse events and their frequency among children who have received oral beta-blockers in a critical care unit setting. The authors aimed to analyze the frequency of adverse events experienced by children treated with oral be...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s00246-014-0899-1
データ提供:米国国立医学図書館(NLM)
Oral Beta-Blockers: A Careful Approach in Pediatric Cardiac Intensive Care
Pediatric patients in cardiac intensive care often require beta-blocker therapy to manage their heart conditions. This research investigates the incidence of adverse events associated with oral beta-blocker administration in a cardiovascular intensive care unit (CVICU) setting. The researchers analyzed the frequency of adverse events and identified potential risk factors in a retrospective study of children receiving oral beta-blockers.
Careful Monitoring and Dosage Management Are Crucial
The study results suggest that adverse events are relatively common among pediatric patients receiving oral beta-blockers in a CVICU setting. The findings highlight the importance of careful monitoring and dosage management to minimize the risk of adverse events. The study identified propranolol as a potential risk factor for adverse events, suggesting that careful consideration should be given to beta-blocker choice and dosage in pediatric patients.
Minimizing Risk and Ensuring Safe Treatment
This research emphasizes the need for cautious and individualized approaches to beta-blocker therapy in pediatric cardiac intensive care. The findings underscore the importance of close monitoring and appropriate dosage adjustments to ensure patient safety and optimize treatment outcomes. It's essential to consult with a healthcare professional to discuss the risks and benefits of beta-blockers and to develop a personalized treatment plan for your child's specific needs.
Dr.Camel's Conclusion
Pediatric cardiac intensive care is like navigating a shifting desert landscape, requiring careful attention to the unique needs of each patient. This research underscores the importance of navigating the use of oral beta-blockers with caution, closely monitoring for potential adverse events. By carefully adjusting dosages and monitoring for potential complications, healthcare professionals can help ensure safe and effective treatment for these vulnerable patients.
Date :
- Date Completed 2015-04-10
- Date Revised 2021-10-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.